Ethiopia Faces Unprecedented Malaria Surge as MSF Responds to Growing Crisis
Ethiopia is grappling with an alarming surge in malaria cases, with the World Health Organization reporting over 7.3 million infections so far in 2024 nearly double the 4.1 million cases reported in 2023.
The sharp increase has placed immense strain on the country’s healthcare system, already stretched by ongoing conflict and the displacement of millions of people.
Médecins Sans Frontières (MSF) is intensifying its response in two of the hardest-hit regions Oromia and Gambella working closely with the Ethiopian Ministry of Health to prevent, treat, and control the spread of the deadly mosquito-borne disease.
MSF’s efforts focus on the most vulnerable populations, including refugees and internally displaced persons (IDPs).
In Oromia, a region struggling with insecurity and limited access to healthcare, malaria cases have skyrocketed by fivefold between August 2023 and August 2024.
The region now accounts for nearly half of the malaria cases reported across the country. MSF began its emergency response in July 2024, setting up dedicated malaria wards in hospitals in Nekemte and Nejo, where around 750 people are treated each week.
Aisha, a mother from Harari region, shared her relief after her children received treatment at one of MSF’s mobile clinics in Oromia. “Luckily, we found MSF’s support,” she said after her children were diagnosed and treated for malaria.
In addition to providing medical care, MSF is conducting health awareness sessions and distributing mosquito nets to prevent further transmission.
One mother, Damaya, whose daughter was severely ill, highlighted the impact of these efforts. “Before, we didn’t use mosquito nets, but after attending MSF’s awareness sessions, I now use nets for my children every night,” she said.
In the Gambella region, home to over 50,000 refugees in Kule camp, malaria cases have surged by 150% compared to last year. MSF’s teams have diagnosed and treated over 36,000 malaria patients in the camp since January 2024.
In response, MSF has implemented indoor residual spraying, reaching over 80% of households, and launched an intermittent preventive treatment program for children.
In addition, MSF is administering the newly WHO-approved R21 malaria vaccine to children under five. As of now, 2,750 children have received the first three doses, with a fourth scheduled after 12 months.
MSF is calling for a targeted, multi-pronged response to address the ongoing malaria epidemic.
This includes improving case management, administering prophylaxis, distributing vaccines, and enhancing vector control measures such as mosquito net distribution and environmental spraying.
With the ongoing crisis and shifting population movements, MSF stresses the need for preparedness in high-risk areas to prevent further escalation of the epidemic.
“Malaria this year has been deadly to so many people,” said Aisha, emphasizing the urgent need for continued support as Ethiopia faces one of the highest malaria burdens in East Africa.